Primary Sjögren's syndrome in men

OBJECTIVE--To describe the clinical expression of primary Sjögren's syndrome (SS) in men, focusing on extraglandular manifestations (EGM) and serological markers of disease. METHODS--In a cross sectional and comparative study, adult men with primary SS were identified from a cohort study on SS,...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
1995
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26793
Acceso en línea:
http://dx.doi.org/10.1136/ard.54.9.748
https://repository.urosario.edu.co/handle/10336/26793
Palabra clave:
Musculoskeletal diseases
Sjogren's syndrome
Gastrointestinal diseases
Rights
License
Abierto (Texto Completo)
id EDOCUR2_1ed000366a9edb57607d087989673ff9
oai_identifier_str oai:repository.urosario.edu.co:10336/26793
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 194747786000130dbe8-9a39-4874-86e1-24613c1d1385-1aef367e9-2ffd-4a11-bd27-55fd9e21f008-16e84280f-9562-41a7-bc79-65a3191228f2-108b284a5-f81e-4269-9101-2f7ffe9f7eed-122a3bd8c-89b4-4c98-b36a-7b77243faeff-12020-08-19T14:40:15Z2020-08-19T14:40:15Z1995-09OBJECTIVE--To describe the clinical expression of primary Sjögren's syndrome (SS) in men, focusing on extraglandular manifestations (EGM) and serological markers of disease. METHODS--In a cross sectional and comparative study, adult men with primary SS were identified from a cohort study on SS, and 26 age matched adult women with primary SS were selected as a control group. All patients met the European classification criteria for SS. They were compared for demographic, clinical and laboratory findings. RESULTS--Thirteen men with primary SS were identified. Mean age at onset was 39 (SEM 4) years and mean duration of disease was 7.8 (1) years. Sicca complex or parotitis was the presenting feature in eight patients (61.5%), and an EGM in five (38.5%). During the course of the disease, EGM were present in 12 patients (92%), polyarthralgias and lymphopenia being the most frequent (38.5% each). Rheumatoid factor was positive in 73% of patients, antinuclear antibodies in 85%, anti-(SS-A) in 62%, and anti-(SS-B) in 46%. No statistical differences in the frequency of EGM or in the presence of autoantibodies were observed between men and women. However, men patients were more likely to have EGM. CONCLUSION--Primary SS in men is an uncommon condition with clinical and serological characteristics similar to those observed in women. Sex hormones may be incriminated in the pathogenesis of SS. However, it remains poorly understood whether sex hormones play a major role in the severity of disease and have any importance with regard to treatment.application/pdfhttp://dx.doi.org/10.1136/ard.54.9.748ISSN: 0003-4967EISSN: 1468-2060https://repository.urosario.edu.co/handle/10336/26793engEuropean League Against RheumatismBMJ Publishing751No. 9748Annals of the Rheumatic DiseasesVol. 54Annals of the Rheumatic Diseases, ISSN: 0003-4967;EISSN: 1468-2060, Vol.54, No.9 (Sept 1995); pp. 748-751https://ard.bmj.com/content/annrheumdis/54/9/748.full.pdfAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Annals of the Rheumatic Diseasesinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURMusculoskeletal diseasesSjogren's syndromeGastrointestinal diseasesPrimary Sjögren's syndrome in menSíndrome de Sjögren primario en hombresarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Anaya, Juan-ManuelLiu, G TSouza, E DOgawa, NLuan, XTalal, N10336/26793oai:repository.urosario.edu.co:10336/267932021-06-03 00:49:59.908https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Primary Sjögren's syndrome in men
dc.title.TranslatedTitle.spa.fl_str_mv Síndrome de Sjögren primario en hombres
title Primary Sjögren's syndrome in men
spellingShingle Primary Sjögren's syndrome in men
Musculoskeletal diseases
Sjogren's syndrome
Gastrointestinal diseases
title_short Primary Sjögren's syndrome in men
title_full Primary Sjögren's syndrome in men
title_fullStr Primary Sjögren's syndrome in men
title_full_unstemmed Primary Sjögren's syndrome in men
title_sort Primary Sjögren's syndrome in men
dc.subject.keyword.spa.fl_str_mv Musculoskeletal diseases
Sjogren's syndrome
Gastrointestinal diseases
topic Musculoskeletal diseases
Sjogren's syndrome
Gastrointestinal diseases
description OBJECTIVE--To describe the clinical expression of primary Sjögren's syndrome (SS) in men, focusing on extraglandular manifestations (EGM) and serological markers of disease. METHODS--In a cross sectional and comparative study, adult men with primary SS were identified from a cohort study on SS, and 26 age matched adult women with primary SS were selected as a control group. All patients met the European classification criteria for SS. They were compared for demographic, clinical and laboratory findings. RESULTS--Thirteen men with primary SS were identified. Mean age at onset was 39 (SEM 4) years and mean duration of disease was 7.8 (1) years. Sicca complex or parotitis was the presenting feature in eight patients (61.5%), and an EGM in five (38.5%). During the course of the disease, EGM were present in 12 patients (92%), polyarthralgias and lymphopenia being the most frequent (38.5% each). Rheumatoid factor was positive in 73% of patients, antinuclear antibodies in 85%, anti-(SS-A) in 62%, and anti-(SS-B) in 46%. No statistical differences in the frequency of EGM or in the presence of autoantibodies were observed between men and women. However, men patients were more likely to have EGM. CONCLUSION--Primary SS in men is an uncommon condition with clinical and serological characteristics similar to those observed in women. Sex hormones may be incriminated in the pathogenesis of SS. However, it remains poorly understood whether sex hormones play a major role in the severity of disease and have any importance with regard to treatment.
publishDate 1995
dc.date.created.spa.fl_str_mv 1995-09
dc.date.accessioned.none.fl_str_mv 2020-08-19T14:40:15Z
dc.date.available.none.fl_str_mv 2020-08-19T14:40:15Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv http://dx.doi.org/10.1136/ard.54.9.748
dc.identifier.issn.none.fl_str_mv ISSN: 0003-4967
EISSN: 1468-2060
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/26793
url http://dx.doi.org/10.1136/ard.54.9.748
https://repository.urosario.edu.co/handle/10336/26793
identifier_str_mv ISSN: 0003-4967
EISSN: 1468-2060
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 751
dc.relation.citationIssue.none.fl_str_mv No. 9
dc.relation.citationStartPage.none.fl_str_mv 748
dc.relation.citationTitle.none.fl_str_mv Annals of the Rheumatic Diseases
dc.relation.citationVolume.none.fl_str_mv Vol. 54
dc.relation.ispartof.spa.fl_str_mv Annals of the Rheumatic Diseases, ISSN: 0003-4967;EISSN: 1468-2060, Vol.54, No.9 (Sept 1995); pp. 748-751
dc.relation.uri.spa.fl_str_mv https://ard.bmj.com/content/annrheumdis/54/9/748.full.pdf
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv European League Against Rheumatism
BMJ Publishing
dc.source.spa.fl_str_mv Annals of the Rheumatic Diseases
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167707566735360